Jacobio Pharmaceuticals Group Co., Ltd.

SZSC:1167 Lagerbericht

Marktkapitalisierung: HK$1.6b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Jacobio Pharmaceuticals Group Management

Management Kriterienprüfungen 3/4

Jacobio Pharmaceuticals Group's CEO is Yinxiang Wang, appointed in Aug 2019, has a tenure of 4.58 years. total yearly compensation is CN¥3.77M, comprised of 61.3% salary and 38.7% bonuses, including company stock and options. directly owns 13.58% of the company’s shares, worth HK$221.56M. The average tenure of the management team and the board of directors is 4.1 years and 4.6 years respectively.

Wichtige Informationen

Yinxiang Wang

Geschäftsführender

CN¥3.8m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts61.3%
Amtszeit als Geschäftsführer4.6yrs
Eigentum des Geschäftsführers13.6%
Durchschnittliche Amtszeit des Managements4.1yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder4.6yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Yinxiang Wang im Vergleich zu den Einnahmen von Jacobio Pharmaceuticals Group verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2023n/an/a

-CN¥410m

Mar 31 2023n/an/a

-CN¥391m

Dec 31 2022CN¥4mCN¥2m

-CN¥372m

Sep 30 2022n/an/a

-CN¥332m

Jun 30 2022n/an/a

-CN¥292m

Mar 31 2022n/an/a

-CN¥297m

Dec 31 2021CN¥4mCN¥2m

-CN¥301m

Vergütung im Vergleich zum Markt: Yinxiang's total compensation ($USD523.20K) is above average for companies of similar size in the Hong Kong market ($USD344.14K).

Entschädigung vs. Einkommen: Yinxiang's compensation has been consistent with company performance over the past year.

Geschäftsführer

Yinxiang Wang (58 yo)

4.6yrs

Amtszeit

CN¥3,766,000

Vergütung

Dr. Yinxiang Wang serves as Consultant at Shining Capital. He is an Executive Chairman at Jacobio Pharmaceuticals Co. Ltd. since August 20, 2020.Dr. Wang has been Director at Jacobio Pharmaceuticals Co. L...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Yinxiang Wang
Executive Chairman & CEO4.6yrsCN¥3.77m13.58%
HK$ 221.6m
Xiaojie Wang
Executive Director & President of Administration8.5yrsCN¥2.86m2.9%
HK$ 47.3m
Yunyan Hu
Executive VP & Executive Director5yrsCN¥2.84m2.94%
HK$ 48.0m
Andrea Wang-Gillam
Executive VP & Chief Medical Officer3.7yrskeine Datenkeine Daten
Qing Xue
Joint Company Secretary3.6yrskeine Datenkeine Daten
Ming Fai Chung
Joint Company Secretary1.6yrskeine Datenkeine Daten

4.1yrs

Durchschnittliche Betriebszugehörigkeit

55yo

Durchschnittliches Alter

Erfahrenes Management: 1167's management team is considered experienced (4.1 years average tenure).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Yinxiang Wang
Executive Chairman & CEO5.8yrsCN¥3.77m13.58%
HK$ 221.6m
Xiaojie Wang
Executive Director & President of Administration5.7yrsCN¥2.86m2.9%
HK$ 47.3m
Yunyan Hu
Executive VP & Executive Director5.7yrsCN¥2.84m2.94%
HK$ 48.0m
Yanmin Tang
Non-Executive Director5.6yrskeine Datenkeine Daten
Ge Wu
Independent Non-Executive Director3.6yrsCN¥200.00kkeine Daten
Ruilin Song
Independent Non-Executive Director3.6yrsCN¥400.00kkeine Daten
Te-li Chen
Non Executive Director3.6yrskeine Datenkeine Daten
Bai Lu
Independent Non-Executive Directorless than a yearkeine Datenkeine Daten

4.6yrs

Durchschnittliche Betriebszugehörigkeit

58.5yo

Durchschnittliches Alter

Erfahrener Vorstand: 1167's board of directors are considered experienced (4.6 years average tenure).